A detailed history of Cohen Klingenstein LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Cohen Klingenstein LLC holds 145,344 shares of JNJ stock, worth $21.7 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
145,344
Previous 148,933 2.41%
Holding current value
$21.7 Million
Previous $23.3 Million 1.51%
% of portfolio
0.89%
Previous 0.99%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$155.22 - $162.74 $557,084 - $584,073
-3,589 Reduced 2.41%
145,344 $23 Million
Q3 2023

Oct 13, 2023

SELL
$155.75 - $174.48 $702,432 - $786,904
-4,510 Reduced 2.94%
148,933 $23.2 Million
Q2 2023

Jul 14, 2023

SELL
$154.35 - $166.11 $56,337 - $60,630
-365 Reduced 0.24%
153,443 $25.4 Million
Q1 2023

Apr 14, 2023

SELL
$151.05 - $180.26 $110,266 - $131,589
-730 Reduced 0.47%
153,808 $23.8 Million
Q2 2022

Jul 15, 2022

SELL
$168.19 - $186.01 $143,802 - $159,038
-855 Reduced 0.55%
154,538 $27.4 Million
Q1 2022

Apr 14, 2022

SELL
$158.14 - $179.59 $105,953 - $120,325
-670 Reduced 0.43%
155,393 $27.5 Million
Q4 2021

Jan 14, 2022

SELL
$155.93 - $173.01 $1.69 Million - $1.88 Million
-10,843 Reduced 6.5%
156,063 $26.7 Million
Q3 2021

Oct 15, 2021

SELL
$161.5 - $179.47 $5.07 Million - $5.63 Million
-31,371 Reduced 15.82%
166,906 $27 Million
Q4 2020

Jan 19, 2021

SELL
$137.11 - $157.38 $3,427 - $3,934
-25 Reduced 0.01%
198,277 $31.2 Million
Q3 2019

Oct 17, 2019

BUY
$126.95 - $142.14 $1.68 Million - $1.88 Million
13,200 Added 7.13%
198,302 $25.7 Million
Q2 2019

Jul 15, 2019

SELL
$131.15 - $144.24 $9.61 Million - $10.6 Million
-73,295 Reduced 28.37%
185,102 $25.8 Million
Q1 2019

Apr 16, 2019

BUY
$125.72 - $139.79 $23.5 Million - $26.1 Million
186,909 Added 261.46%
258,397 $36.1 Million
Q3 2017

Oct 17, 2017

BUY
$129.47 - $135.38 $9.26 Million - $9.68 Million
71,488
71,488 $9.29 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $391B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cohen Klingenstein LLC Portfolio

Follow Cohen Klingenstein LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohen Klingenstein LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cohen Klingenstein LLC with notifications on news.